Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongmai Yangxin Pills for prevention of anthracycline-related myocardial injury in breast cancer
ChiCTR-IPC-15006295Phase 2Not yet recruiting
- Sponsor
- The First Hospital of Henan University of Chinese Medicine
- Start
- Jan 2015
- Countries
- 1
01
Overview
Phase 2 trial of Tongmai Yangxin Pills in Myocardial injury (2 arms), sponsored by The First Hospital of Henan University of Chinese Medicine. Primary endpoint: myocardial enzymes. Planned start Jan 2015; status: not yet recruiting.
02
Drugs
Tongmai Yangxin Pills
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on ChiCTR-IPC-15006295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPC-15006295.